• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尾加压素II受体的生物学特性与功能决定因素

Biological properties and functional determinants of the urotensin II receptor.

作者信息

Proulx Christophe D, Holleran Brian J, Lavigne Pierre, Escher Emanuel, Guillemette Gaétan, Leduc Richard

机构信息

Department of Pharmacology, Faculty of Medicine and Health Sciences, Université de Sherbrooke, 3001, 12th Avenue North, Sherbrooke, Quebec, J1H 5N4 Canada.

出版信息

Peptides. 2008 May;29(5):691-9. doi: 10.1016/j.peptides.2007.10.027. Epub 2007 Nov 17.

DOI:10.1016/j.peptides.2007.10.027
PMID:18155322
Abstract

The urotensin II receptor (UT) is a member of the G protein-coupled receptor (GPCR) family and binds the cyclic undecapeptide urotensin II (U-II) as well as the octapeptide urotensin II-related peptide (URP). The active UT mediates pleiotropic effects through various signal transduction pathways, including coupling to G proteins and activating the mitogen-activated protein kinase pathway. Several highly conserved residues and motifs of class A GPCRs that are important for activity are found in UT. This review highlights some of the putative roles of these motifs in the binding, activation and desensitization of UT.

摘要

尾加压素II受体(UT)是G蛋白偶联受体(GPCR)家族的成员,可结合环十一肽尾加压素II(U-II)以及八肽尾加压素II相关肽(URP)。活性UT通过多种信号转导途径介导多效性作用,包括与G蛋白偶联并激活丝裂原活化蛋白激酶途径。在UT中发现了A类GPCR的几个对活性很重要的高度保守的残基和基序。本文综述重点介绍了这些基序在UT的结合、激活和脱敏中的一些假定作用。

相似文献

1
Biological properties and functional determinants of the urotensin II receptor.尾加压素II受体的生物学特性与功能决定因素
Peptides. 2008 May;29(5):691-9. doi: 10.1016/j.peptides.2007.10.027. Epub 2007 Nov 17.
2
Solution structure of urotensin-II receptor extracellular loop III and characterization of its interaction with urotensin-II.
Peptides. 2008 May;29(5):700-10. doi: 10.1016/j.peptides.2008.02.024.
3
Photolabelling the urotensin II receptor reveals distinct agonist- and partial-agonist-binding sites.用光标记尾加压素II受体可揭示不同的激动剂和部分激动剂结合位点。
Biochem J. 2007 Feb 15;402(1):51-61. doi: 10.1042/BJ20060943.
4
Another ligand fishing for G protein-coupled receptor 14. Discovery of urotensin II-related peptide in the rat brain.另一种寻找G蛋白偶联受体14的配体。大鼠脑中尾加压素II相关肽的发现。
Peptides. 2008 May;29(5):809-12. doi: 10.1016/j.peptides.2007.06.005. Epub 2007 Jun 13.
5
Structure-activity relationships of urotensin II and URP.尾加压素II与尾加压素相关肽的构效关系。
Peptides. 2008 May;29(5):658-73. doi: 10.1016/j.peptides.2007.08.014. Epub 2007 Aug 19.
6
Characterization of urotensin II, distribution of urotensin II, urotensin II-related peptide and UT receptor mRNAs in mouse: evidence of urotensin II at the neuromuscular junction.小鼠中尾加压素 II 的特性、尾加压素 II、尾加压素 II 相关肽及 UT 受体 mRNA 的分布:尾加压素 II 存在于神经肌肉接头处的证据
J Neurochem. 2008 Oct;107(2):361-74. doi: 10.1111/j.1471-4159.2008.05624.x. Epub 2008 Aug 14.
7
Molecular mechanisms of ligand binding, signaling, and regulation within the superfamily of G-protein-coupled receptors: molecular modeling and mutagenesis approaches to receptor structure and function.G蛋白偶联受体超家族内配体结合、信号传导及调节的分子机制:受体结构与功能的分子建模及诱变方法
Pharmacol Ther. 2004 Jul;103(1):21-80. doi: 10.1016/j.pharmthera.2004.05.002.
8
Identification of transmembrane domain 6 & 7 residues that contribute to the binding pocket of the urotensin II receptor.鉴定对尾加压素II受体结合口袋有贡献的跨膜结构域6和7残基。
Biochem Pharmacol. 2009 Apr 15;77(8):1374-82. doi: 10.1016/j.bcp.2009.01.013. Epub 2009 Jan 29.
9
Increased expression of urotensin II-related peptide and its receptor in kidney with hypertension or renal failure.高血压或肾衰竭患者肾脏中尾加压素II相关肽及其受体的表达增加。
Peptides. 2009 Feb;30(2):400-8. doi: 10.1016/j.peptides.2008.09.021. Epub 2008 Oct 8.
10
Ligand-supported purification of the urotensin-II receptor.配体支持的尾加压素 II 受体的纯化。
Mol Pharmacol. 2010 Oct;78(4):639-47. doi: 10.1124/mol.110.065151. Epub 2010 Jul 20.

引用本文的文献

1
Inhibition of U-II/UT signaling ameliorates cystitis-associated bladder hyperactivity by targeting the RhoA/Rho-kinase pathway.抑制 U-II/UT 信号通过靶向 RhoA/Rho 激酶通路改善膀胱炎相关的膀胱过度活动症。
Kaohsiung J Med Sci. 2022 Sep;38(9):879-888. doi: 10.1002/kjm2.12569. Epub 2022 Jun 29.
2
The roles of potassium channels in contractile response to urotensin-II in mercury chloride induced endothelial dysfunction in rat aorta.钾通道在氯化汞诱导的大鼠主动脉内皮功能障碍中对尾加压素II收缩反应中的作用。
Iran J Vet Res. 2018 Summer;19(3):208-216.
3
Urantide improves the structure and function of right ventricle as determined by echocardiography in monocrotaline-induced pulmonary hypertension rat model.
乌瑞替德通过超声心动图改善野百合碱诱导的肺动脉高压大鼠模型右心室的结构和功能。
Clin Rheumatol. 2019 Jan;38(1):29-35. doi: 10.1007/s10067-018-3978-5. Epub 2018 Jan 23.
4
Urotensin II receptor as a potential biomarker for the prognosis of hepatocellular carcinoma patients.尾加压素II受体作为肝细胞癌患者预后的潜在生物标志物。
Oncol Lett. 2017 Sep;14(3):2749-2756. doi: 10.3892/ol.2017.6545. Epub 2017 Jul 8.
5
The G Protein-Coupled Receptor UT of the Neuropeptide Urotensin II Displays Structural and Functional Chemokine Features.神经肽尾加压素II的G蛋白偶联受体UT具有结构和功能趋化因子特征。
Front Endocrinol (Lausanne). 2017 Apr 25;8:76. doi: 10.3389/fendo.2017.00076. eCollection 2017.
6
Oncogenic effects of urotensin-II in cells lacking tuberous sclerosis complex-2.血管紧张素 II 在缺乏结节性硬化复合物 2 的细胞中的致癌作用。
Oncotarget. 2016 Sep 20;7(38):61152-61165. doi: 10.18632/oncotarget.10748.
7
Urotensin-ⅡReceptor Antagonist SB-710411 Protects Rat Heart against Ischemia-Reperfusion Injury via RhoA/ROCK Pathway.尾加压素 II 受体拮抗剂 SB - 710411 通过 RhoA/ROCK 信号通路保护大鼠心脏免受缺血再灌注损伤。
PLoS One. 2016 Jan 15;11(1):e0146094. doi: 10.1371/journal.pone.0146094. eCollection 2016.
8
Urotensin II promotes vagal-mediated bradycardia by activating cardiac-projecting parasympathetic neurons of nucleus ambiguus.尾加压素 II 通过激活孤束核中的心脏投射副交感神经元促进迷走神经介导的心动过缓。
J Neurochem. 2014 May;129(4):628-36. doi: 10.1111/jnc.12679. Epub 2014 Mar 6.
9
Update on the urotensinergic system: new trends in receptor localization, activation, and drug design.关于尿皮质素系统的最新研究进展:受体定位、激活及药物设计的新趋势。
Front Endocrinol (Lausanne). 2013 Jan 2;3:174. doi: 10.3389/fendo.2012.00174. eCollection 2012.
10
Urotensin-II: More Than a Mediator for Kidney.尾加压素II:不仅仅是一种肾脏介质。
Int J Nephrol. 2012;2012:249790. doi: 10.1155/2012/249790. Epub 2012 Oct 10.